Cardiac Monitoring And Cardiac Rhythm Management Devices Market To Reach $49.78 Billion By 2033

Cardiac Monitoring And Cardiac Rhythm Management Devices Market Growth & Trends

The global cardiac monitoring and cardiac rhythm management devices market size is estimated to reach USD 49.78 billion by 2033, expanding at a CAGR of 6.55% from 2026 to 2033, according to a new report by Grand View Research, Inc. Increasing incidence of cardiovascular diseases and advancement in medical devices is driving the market.

Cardiovascular disorders, such as ischemic heart disease, are one of the leading causes of death globally. According to the CDC, the prevalence of cardiovascular diseases and the number of deaths has remained steady with almost 31.0% of the population dying due to such diseases in 2017. Moreover, the incidence of obesity has increased over the past few years; an estimated 37.7% of adults in the U.S. are obese. In addition, in 2016, about 18.0% of the U.S. adults had high-density lipoprotein cholesterol levels of less than 40 mg/dL. Industry players are trying to develop advanced medical devices for cardiovascular disorders, which is propelling the market.

The hospital segment held the largest market share in terms of revenue in 2019. Hospitals are able to provide optimal care of the patients suffering from cardiovascular disorders by efficiently monitoring and diagnosing the problem at an early stage. This, in turn, is anticipated to augment the growth of the segment in the market.

The home care segment is expected to witness significant growth over the forecast period owing to ease of treatment and cost-effectiveness provided by the system. Miniaturization of medical devices required to monitor cardiovascular events at remote places is anticipated to drive the driving segment in the coming years.

North America held the largest revenue share in 2019 owing to the increasing geriatric population in the region. In addition, rapid technological advancements in medical devices such as miniaturization, long battery life, the use of biocompatible materials are also stimulating the growth of the market in the region. Moreover, rising cases of cardiovascular disorders including heart failure and cardiovascular arrests are expected to propel market growth in the region.

In Asia Pacific, the market is anticipated to witness significant growth over the forecast period. This is attributed to the rising demand for quality healthcare services in the region. The growing number of an aging population in countries including India, Japan, and China is driving demand for advanced medical devices in the region.

 Request a free sample copy or view report summary: Cardiac Monitoring And Cardiac Rhythm Management Devices Market Report

Cardiac Monitoring And Cardiac Rhythm Management Devices Market Report Highlights

• The cardiac rhythm management devices segment dominated the market with a revenue share of 73.61% in 2025 due to the increasing prevalence of cardiovascular diseases, particularly arrhythmias and heart failure.

• The hospital segment dominated the market by end use, with a revenue share of 53.43% in 2025, which can be attributed to their capability to provide comprehensive care for patients with complex cardiac conditions.

• North America cardiac monitoring and cardiac rhythm management devices market held the highest revenue share of 45.64% in 2025 due to substantial healthcare spending and a well-developed medical infrastructure.

• The Asia Pacific cardiac monitoring and cardiac rhythm management devices industry is expected to register the fastest growth rate over the forecast period, which can be attributed to rapid urbanization and a rise in lifestyle-related diseases.

Cardiac Monitoring And Cardiac Rhythm Management Devices Market Segmentation

Grand View Research has segmented the global cardiac monitoring and cardiac rhythm management devices market based on product, end use, and region:

Cardiac Monitoring And Cardiac Rhythm Management Devices Product Outlook (Unit Volume in ‘000 Units; Average Selling Price in USD per Unit; Revenue in USD Million, 2021 - 2033)

• Cardiac Monitoring Devices

  • ECG

  • Implantable Cardiac Monitors

  • Holter Monitors

  • Mobile Cardiac Telemetry

• Cardiac Rhythm Management Devices

  • Pulse Generators

    • Cardiac Resynchronization Therapy (CRT)

      • CRT-Defibrillator

      • CRT-Pacemakers

    • Defibrillators

      • Implantable Cardioverter Defibrillators (ICD)

      • Transvenous Implantable Cardioverter Defibrillators (TIICDs)

        • Single Chamber

        • Dual Chamber

      • Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)

      • External Defibrillator.

    • Pacemakers

      • Conventional Pacemakers

      • Leadless Pacemakers

  • Leads

    • Pacing Leads

      • Standard RV/LV Leads

      • Conduction System Pacing (CSP) / LBBAP Leads

    • Defibrillator Leads

      • Traditional Leads

      • LV Leads

Cardiac Monitoring And Cardiac Rhythm Management Devices End Use Outlook (Revenue USD Million, 2021 - 2033)

• Hospitals

• Ambulatory Surgery Centers

• Others

Cardiac Monitoring And Cardiac Rhythm Management Devices Regional Outlook (Unit Volume in ‘000 Units; Average Selling Price in USD per Unit; Revenue in USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Cardiac Monitoring And Cardiac Rhythm Management Devices Market

• Stryker

• Medtronic

• Abbott

• Boston Scientific Corporation

• Koninklijke Philips N.V.

• ZOLL Medical Corporation. (Asahi Kasei company)

• GE HealthCare

• MicroPort Scientific Corporation

• NIHON KOHDEN CORPORATION

• Biotronik SE & Co KG